Publication Brief
The Quanterix Simoa® platform, known for ultrasensitive detection in plasma, serum, and CSF, now delivers the same performance in alternative matrices—urine, saliva, sweat, and tears.
This publication brief features peer-reviewed studies where Simoa enabled high-quality biomarker analysis with minimal assay adjustments, opening doors to minimally invasive sampling and decentralized research.
What’s inside:
- Urine-based TB detection with 98% specificity
- Saliva for COVID-19 antibody and antigen detection
- Tear biomarkers in Parkinson’s and ocular inflammation
- Sweat cytokines linked to aging and behavioral health
Simoa is expanding what’s possible in translational and real-world research. Download the publication brief now.